Stay updated on Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.0 to v3.6.3, indicating a newer revision of the study record page. This reflects internal maintenance and does not change the study data or primary content.
    Difference
    0.1%
    Check dated 2026-06-30T01:00:32.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Introduces a recruitment notice and new navigation aids to help users understand and join the study; includes a minor formatting change to the Intervention header and a new revision tag (v3.6.0).
    Difference
    0.4%
    Check dated 2026-06-15T22:56:33.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This reflects a new build/version of the page.
    Difference
    0.1%
    Check dated 2026-06-09T01:41:22.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page revision tag has been updated to v3.5.4, replacing v3.5.3, signaling a minor update to the page version.
    Difference
    0.1%
    Check dated 2026-05-18T13:52:06.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The page now shows an updated “Revision” identifier for the ClinicalTrials.gov interface (v3.5.3 instead of v3.5.2), reflecting a software/content template update rather than a change to the clinical study details.
    Difference
    0.1%
    Check dated 2026-04-27T07:33:36.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-20T02:16:52.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.